Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00649103 | Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg | PHASE1 | COMPLETED | 60 | — | — | Dec 1, 2002 | Jan 1, 2003 | Apr 24, 2024 | 1 | United States |
| NCT00649649 | Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg | PHASE1 | COMPLETED | 24 | — | — | Dec 1, 2002 | Jan 1, 2003 | Apr 24, 2024 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Quinapril Hydrochloride Tablets 40 mg |
| 2 | ACTIVE_COMPARATOR | Accupril® Tablets 40 mg |
| Name | Type | Description |
|---|---|---|
| Quinapril Hydrochloride Tablets 40 mg | DRUG | 40mg, single dose fasting |
| Accupril® Tablets 40 mg | DRUG | 40mg, single dose fasting |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female 1. Women of childbearing potential must have negative serum beta-human chorionic gonadotropin (HCG) pregnancy tests performed within 14 days prior to of the study and on the evening prior to e...